Keywords: update, novartis, glivec, oked, first-line, cml, swiss

Update - Novartis' Glivec OKed for first-line CML

Article | 06 January 2003

Print This

Swiss drug major Novartis has reported that its Gleevec/ Glivec(imatinib mesylate) has been approved in both the USA and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in